291 related articles for article (PubMed ID: 10557058)
1. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.
Emig M; Saussele S; Wittor H; Weisser A; Reiter A; Willer A; Berger U; Hehlmann R; Cross NC; Hochhaus A
Leukemia; 1999 Nov; 13(11):1825-32. PubMed ID: 10557058
[TBL] [Abstract][Full Text] [Related]
2. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
[TBL] [Abstract][Full Text] [Related]
3. Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.
Amabile M; Giannini B; Testoni N; Montefusco V; Rosti G; Zardini C; Terragna C; Buonamici S; Ottaviani E; Soverini S; Fiacchini M; Bassi S; de Vivo A; Trabacchi E; Saglio G; Pane F; Baccarani M; Tura S; Martinelli G
Haematologica; 2001 Mar; 86(3):252-9. PubMed ID: 11255271
[TBL] [Abstract][Full Text] [Related]
4. Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation.
Neumann F; Herold C; Hildebrandt B; Kobbe G; Aivado M; Rong A; Free M; Rössig R; Fenk R; Schneider P; Gattermann N; Royer-Pokora B; Haas R; Kronenwett R
Eur J Haematol; 2003 Jan; 70(1):1-10. PubMed ID: 12631253
[TBL] [Abstract][Full Text] [Related]
5. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB
Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
[TBL] [Abstract][Full Text] [Related]
6. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
Preudhomme C; Révillion F; Merlat A; Hornez L; Roumier C; Duflos-Grardel N; Jouet JP; Cosson A; Peyrat JP; Fenaux P
Leukemia; 1999 Jun; 13(6):957-64. PubMed ID: 10360386
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
[TBL] [Abstract][Full Text] [Related]
8. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML.
Kim YJ; Kim DW; Lee S; Kim HJ; Kim YL; Hwang JY; Oh IH; Park YH; Lee YK; Min CK; Kim TG; Han TH; Min WS; Kim CC
Eur J Haematol; 2002 May; 68(5):272-80. PubMed ID: 12144533
[TBL] [Abstract][Full Text] [Related]
10. Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia.
Hessner MJ; Roth MS; Drobyski WR; Baxter-Lowe LA
Genet Anal Tech Appl; 1994; 11(4):90-4. PubMed ID: 7857690
[TBL] [Abstract][Full Text] [Related]
11. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
Bolufer P; Sanz GF; Barragán E; Sanz MA; Cervera J; Lerma E; Senent L; Moreno I; Planelles MD
Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
[TBL] [Abstract][Full Text] [Related]
12. Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.
Saussele S; Weisser A; Müller MC; Emgi M; La Rosée P; Paschka P; Kuhn C; Willer A; Hehlmann R; Hochhaus A
Leukemia; 2000 Nov; 14(11):2006-10. PubMed ID: 11069038
[TBL] [Abstract][Full Text] [Related]
13. Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy.
Hochhaus A; Reiter A; Skladny H; Reichert A; Saussele S; Hehlmann R
Recent Results Cancer Res; 1998; 144():36-45. PubMed ID: 9304705
[TBL] [Abstract][Full Text] [Related]
14. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
[TBL] [Abstract][Full Text] [Related]
15. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.
Hochhaus A; Lin F; Reiter A; Skladny H; Mason PJ; van Rhee F; Shepherd PC; Allan NC; Hehlmann R; Goldman JM; Cross NC
Blood; 1996 Feb; 87(4):1549-55. PubMed ID: 8608246
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
17. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
Wang WJ; Zheng CF; Liu Z; Tan YH; Chen XH; Zhao BL; Li GX; Xu ZF; Ren FG; Zhang YF; Chang JM; Wang HW
Eur J Haematol; 2018 Sep; 101(3):291-296. PubMed ID: 29691899
[TBL] [Abstract][Full Text] [Related]
18. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
Preudhomme C; Chams-Eddine L; Roumier C; Duflos-Grardel N; Denis C; Cosson A; Fenaux P
Leukemia; 1999 May; 13(5):818-23. PubMed ID: 10374889
[TBL] [Abstract][Full Text] [Related]
19. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage.
Elmaagacli AH; Beelen DW; Opalka B; Seeber S; Schaefer UW
Ann Hematol; 2000 Aug; 79(8):424-31. PubMed ID: 10985361
[TBL] [Abstract][Full Text] [Related]
20. Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.
Lee YK; Lee DW; Kim YL; Lee S; Min CK; Kim YJ; Oh IH; Kim TG; Kim CC; Kim DW
Int J Hematol; 2002 Aug; 76(2):180-5. PubMed ID: 12215018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
